Effects of an L-Leucine-Rich Diet on Liver and Kidneys in a Doxorubicin Toxicity Model

• Published in: Life (Basel, Switzerland) Vol. 13; no. 9; p. 1823
• Main Authors: Duarte, Poliana Rodrigues Alves, Franco, Rodrigo Rodrigues, Vilela, Danielle Diniz, Caixeta, Douglas Carvalho, de Souza, Adriele Vieira, Deconte, Simone Ramos, Mendes-Rodrigues, Clesnan, Fidale, Thiago Montes, Espindola, Foued Salmen, Teixeira, Renata Roland, Resende, Elmiro Santos
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-08-2023; MDPI
• Subjects: Amino acids; Animal models; Animal tissues; Animals; antioxidant status; Antioxidants; BCAA; Biomarkers; Cancer; Cancer therapies; Catalysis; Chain branching; Complications and side effects; Diet; Dietary supplements; Doxorubicin; Drugs; Health aspects; histological parameters; Kidney diseases; Kidneys; L-leucine; Leucine; Liver; Liver diseases; Mathematical models; Nutrition research; Organs; Oxidation; Oxidative stress; Parameters; Potassium; Proteins; Risk factors; Toxicity; Brazil
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life13091823

Supplements and diets containing L-leucine, a branched-chain amino acid, have been considered beneficial for controlling oxidative stress and maintaining cardiac tissue in toxicity models using doxorubicin, a drug widely used in cancer treatment. However, there is a lack of studies in the literature that assess the effects of this diet on other organs and tissues, such as the liver and kidneys. Therefore, this study aimed to evaluate the effects of a leucine-rich diet on the liver and kidneys of healthy rats submitted to the doxorubicin toxicity model by analyzing biomarkers of oxidative stress and histological parameters. The animals were divided into four groups: naive, doxorubicin, L-leucine, and doxorubicin + L-leucine, and the diet was standardized with 5% L-leucine and a dose of 7.5 mg/kg of doxorubicin. We evaluated tissue injury parameters and biomarkers of oxidative stress, including enzymes, antioxidant profile, and oxidized molecules, in the liver and kidneys. Although some studies have indicated benefits of a diet rich in L-leucine for the muscle tissue of animals that received doxorubicin, our results showed that the liver was the most affected organ by the L-leucine-rich diet since the diet reduced its antioxidant defenses and increased the deposit of collagen and fat in the hepatic tissue. In the kidneys, the main alteration was the reduction in the number of glomeruli. These results contribute to the scientific literature and encourage further studies to evaluate the effects of an L-leucine-rich diet or its supplementation, alone or combined with doxorubicin using an animal model of cancer. Therefore, our study concludes that the leucine-rich diet itself was harmful and, when co-administered with doxorubicin, was not able to maintain the antioxidant defenses and tissue structure of the evaluated organs.